Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-2-14
pubmed:abstractText
The aim of this study was to evaluate the efficacy and toxicity of a new combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in the treatment of metastatic urothelial cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0368-2811
pubmed:author
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
79-83
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:15709091-Aged, pubmed-meshheading:15709091-Aged, 80 and over, pubmed-meshheading:15709091-Agranulocytosis, pubmed-meshheading:15709091-Anemia, pubmed-meshheading:15709091-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15709091-Bone Neoplasms, pubmed-meshheading:15709091-Cisplatin, pubmed-meshheading:15709091-Drug Administration Schedule, pubmed-meshheading:15709091-Female, pubmed-meshheading:15709091-Humans, pubmed-meshheading:15709091-Ifosfamide, pubmed-meshheading:15709091-Lung Neoplasms, pubmed-meshheading:15709091-Lymphatic Metastasis, pubmed-meshheading:15709091-Male, pubmed-meshheading:15709091-Middle Aged, pubmed-meshheading:15709091-Soft Tissue Neoplasms, pubmed-meshheading:15709091-Taxoids, pubmed-meshheading:15709091-Thrombocytopenia, pubmed-meshheading:15709091-Urologic Neoplasms
pubmed:year
2005
pubmed:articleTitle
Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report.
pubmed:affiliation
Department of Urology, Faculty of Medicine, Tokyo University, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. takahashi-uro@h.u-tokyo.ac.jp
pubmed:publicationType
Journal Article, Clinical Trial